In this episode of the American Brachytherapy Society podcast, we sit down with Michael Krachon, President of Theragenics International, and Lory Bradley, a seasoned industry expert with decades of experience in prostate brachytherapy. Together, they reflect on the evolution of the field—from the early days of seed implants to modern-day innovations and challenges.Michael shares insights from his long career in the prostate seed business, highlighting the pivotal role of physician partnerships, the rise and fall of brachytherapy utilization, and the path forward for restoring its prominence in prostate cancer care. Lory offers additional perspective on the clinical and logistical advancements that have shaped practice patterns over time.Whether you're a clinician, trainee, or industry partner, this episode provides valuable historical context, practical wisdom, and a hopeful outlook for the future of LDR brachytherapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related